SEC Comment Letter 0000000000-23-001562 to Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO)
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: Feb. 15, 2023 · CIK: 0001429260 · Accession: 0000000000-23-001562
AI Filing Summary & Sentiment
File numbers found in text: 333-269687
Letter
United States securities and exchange commission logo February 15, 2023 Lindsay Rosenwald, M.D. Chief Executive Officer Fortress Biotech, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands, FL 33154 Re:Fortress Biotech, Inc. Registration Statement on Form S-3 Filed February 10, 2023 File No. 333-269687 Dear Lindsay Rosenwald: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew B. Chmiel
Show Raw Text
United States securities and exchange commission logo
February 15, 2023
Lindsay Rosenwald, M.D.
Chief Executive Officer
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, FL 33154
Re:Fortress Biotech, Inc.
Registration Statement on Form S-3
Filed February 10, 2023
File No. 333-269687
Dear Lindsay Rosenwald:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Matthew B. Chmiel